Home / Companies / Company Results /  Cipla Q3 Results: Net profit rises by 10% to 801 cr, revenue up 5.2%

Cipla Ltd on Wednesday reported 9.93 per cent rise in consolidated net profit to 800.96 crore for the quarter ended December 2022. This is against a net profit of 728.60 crore in the corresponding quarter last fiscal.

The revenue from operations of Cipla rose by 5.2 per cent to 5,730.08 as against 5,442.86 in the corresponding quarter last fiscal.

On a sequential basis, the consolidated net profit was up by 1.52 per cent from 788.90 crore in the September quarter.

The earnings before interest, taxes, depreciation and amortization (EBITDA) grew 14.3 per cent on year to 1,407.56 crore, as against 1,231 crore, while the margins expanded by 170 bps to 24.2 per cent.

The revenue from operations of pharmaceutical segment of Cipla rose by nearly 4 per cent to 5,588.87 crore as against 5,377.28 crore on a yearly basis. While the new ventures revenue stood at 312.26 crore.

Cipla’s standalone net profit for theDecember quarter fell 7.2per cent to 678.52 crore against 730.83 crore in corresponding quarter last fical. The revenue grew a marginal 0.4 per cent to 3,899.45 crore on year from 3,883.60 crore.

Recently, Cipla Ltd said that its wholly-owned UK subsidiary, Cipla (EU) Limited has acquired 10.35 per cent stake in Germany's Ethris GmbH.

Cipla EU will invest Euro 15 million for acquisition of 9,939 common shares of face value of Euro 1 each, for a stake of 10.35 per cent, said the company in its regulatory filing.

The company's scrip was down by 2.97 per cent to 1030 on BSE.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less

Recommended For You

Trending Stocks

Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout